US-based health technology company DeepScribe has announced the introduction of a new ambient intelligence tool, DeepScribe Assist, to improve healthcare documentation and compliance for healthcare organisations.

This offering utilises structured data from patient conversations, offering clinicians immediate feedback to improve risk-adjusted outcomes.

Currently, several health systems are employing DeepScribe Assist's initial application.

By analysing patient-clinician conversations, the technology identifies significant Hierarchical Condition Categories (HCCs) for patients to guarantee the recording of accurate diagnosis codes.

This approach is crucial in delivering high-quality care and meeting the requirements of value-based care programmes.

DeepScribe chief medical officer Dean Dalili said: “Physicians often face challenges documenting the severity of illness in a way that meets compliance standards.

“This is a growing concern given the prevalence of ACO Reach and MSSP programs, and the expanding number of patients on Medicare Advantage plans. DeepScribe Assist allows clinicians to focus on patient care while our ambient intelligence handles the documentation intricacies.”

HCCs are said to be essential for evaluating the complexity and severity of a patient's health conditions.

Accurate HCC documentation provides risk-bearing providers with a comprehensive view of a patient's disease burden, enabling the adoption of well-informed clinical decisions and crafting personalised care plans.

DeepScribe Assist works in conjunction with electronic health records to compile a list of HCC-related conditions that may need attention for each patient.

During the visit, the ambient AI technology summarises the conversation, paying particular attention to details that satisfy the Monitor, Evaluate, Assess, Treat (MEAT) criteria for the conditions.

Post-visit, DeepScribe Assist presents the clinician with a detailed draft of the clinical note and a summary indicating whether the MEAT criteria were met for each condition, ensuring documentation is both accurate and complete.

DeepScribe CEO and co-founder Matthew Ko said: “This continues our dedication to helping clinicians deliver the best possible care without distraction.

“DeepScribe Assist delivers real-time insights at the point of care, while our ambient AI scribe tool seamlessly documents the care informed by those insights.” 

In March this year, the company launched the ‘Real-Time’ feature, providing clinicians with AI-generated clinical notes simultaneously as patient encounters take place.